Scarica l'app Stockscreener
1.68
8.20%
-0.15
Dopo l'orario di chiusura:
1.66
-0.02
-1.19%
Celularity Inc Borsa (CELU) Ultime notizie
Celularity and MuseCell Innovations Strike New Jersey Manufacturing Deal Worth Up to $300 Million - BioBuzz
Celularity and MuseCell Innovations strike US manufacturing deal with potential $300m upside & 200 jobs - Indian Pharma Post
Celularity Inc (CELUW) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Celularity Manufacturing Deal Could Bring $300 Million, 200 Jobs to Florham Park - morrisfocus.com
Celularity (CELU) Stock News & Analysis - TechStock²
Celularity shares jump 138.5% after forecasting $300 million MuseCell manufacturing revenue - TechStock²
Celularity Partners with MuseCell Innovations to Manufacture Allogeneic Cell Therapy Products in the US - BioPharm International
Celularity and MuseCell Innovations® Announce U.S. Manufacturing Collaboration for the Dezawa MuseCell® Platform - Investing News Network
Why Is Celularity Stock Gaining Thursday? - Benzinga
Florham Park Facility at Center of Cell Therapy Manufacturing Deal Worth Up to $300 Million - centraljersey.com
Celularity and MuseCell Innovations announce manufacturing collaboration - ROI-NJ
$Celularity (CELU.US)$ It's 100% happening, guys - Moomoo
Singapore's MuseCell Innovations announces manufacturing collaboration with Celularity in US - BioSpectrum Asia
Celularity And MuseCell Innovations® Announce U.S. Manufacturing Collaboration For The Dezawa Musecell® Platform - tradingview.com
Celularity to manufacture Dezawa MuseCells for MuseCell Innovations By Investing.com - Investing.com India
Celularity (NASDAQ:CELU): Why Is It in Focus After It provided a fresh Nasdaq listing-compliance update? - Kalkine Media
Celularity Provides Update Regarding Nasdaq Listing Compliance - The Manila Times
Celularity Inc. Receives Nasdaq Notice for Late Quarterly Filings, Working to Regain Compliance - Quiver Quantitative
Celularity (CELU) Latest Quarter: The Bottom-Line Figure Outpaces Its Comparison in the Current Update; Shares Move Lower 2.01% on the DayDividend Earnings Report - vinanet.vn
Celularity (CELU) Levels: Finishes 1.41% Down at $0.77 in Latest Trading; Range Check: the Near-Term Reference Band Stretches From $0.73 to $0.81 under the Current SnapshotPrice Momentum Stocks - vinanet.vn
Celularity (CELU) Earnings Snapshot: The EPS Result Is Above Expectation on the Day; Share Move: Shares Move 5.89% Higher in the Current UpdateEPS Surprise History - vinanet.vn
Nexgel’s Celularity Deal: Execution, Integration, and Profitability Risks from $13.3 Million Biomaterials Acquisition - TipRanks
NEXGEL Q2 2026: Revenue $3.69M, Net Loss $2.87M as Company Transitions Post-Acquisition - TradingView
Celularity Delays Quarterly SEC Filing - TipRanks
Celularity (CELU) delays June 2026 10-Q filing amid liquidity and staffing strain - Stock Titan
Celularity Data Published in Journal for ImmunoTherapy of Cancer Reveals Benefits of Placental Circulating T Cells for CAR-T Therapy - Stock Titan
CELU Q4 2025 Earnings: Narrower Loss Beats Estimates by 44.44% as Shares Rise 0.72Profit Margin Analysis - vinanet.vn
Celularity (CELU) Slips 2% as Stock Holds Between $0.66 Support and $0.72 ResistanceFast Moving Stocks - dars.gov.et
Celularity Announces Sudden Exit of Chief Commercial Officer - The Globe and Mail
Celularity Inc. Files Form 8-K as Emerging Growth Company on NASDAQ CELU Shares - Minichart
Celularity removes chief commercial officer Rick Gonzalez effective immediately - Investing.com
Form 8K Celularity Inc For: 7 August By Investing.com - Investing.com Nigeria
Celularity terminates Rick Gonzalez as Chief Commercial Officer - TradingView
Celularity (NASDAQ: CELU) terminates employment of chief commercial officer - Stock Titan
Celularity Inc Announces Termination of Rick Gonzalez from Chief Commercial Officer, Effective August 5, 2026 - marketscreener.com
Celularity Inc (CELU) Stock News Today - TradingKey
Celularity removes chief commercial officer Rick Gonzalez effective immediately By Investing.com - Investing.com Canada
Celularity Inc (CELU) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Celularity Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
CELU|Celularity Inc|Price:0.780|Chg%:+0.030 - TradingKey
Celularity Inc (CELU) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Celularity Inc (CELU) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Celularity Inc (CELU) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Celularity Inc (CELU) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Celularity Inc (CELU) Valuation: PE, PB & Fair Value Analysis - TradingKey
Celularity Inc (CELU) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Celularity Inc (CELU) Institutional Confidence - TradingKey
Celularity Inc (CELU) Income Statement - TradingKey
TradingKey - TradingKey
Celularity Inc. (CELU) Q4 2025 Earnings: Narrower-Than-Expected Loss as Operational Discipline ImprovesSegment Revenue Breakdown - dars.gov.et
Philip & Daniele Barach Family Trust Net Worth (2026) - GuruFocus
Celularity Inc. (CELU) Q4 2025 Earnings: EPS Surprise Beats Estimates as Losses Narrow SharplyRevenue Recognition Risk - dars.gov.et
Celularity Inc. (CELU) warrants delisted and deregistered from Nasdaq exchange - Stock Titan
Celularity Inc. (CELU) Edges Higher as Stock Tests Resistance Near $0.83Synthetic Short - dars.gov.et
CELU Q4 2025 Earnings: EPS Beat Signals Cost Discipline Despite Revenue AbsenceOne-Time Gain Impact - vinanet.vn
Celularity Q4 2025 Earnings: EPS Surpasses Estimates by 44.4% Amid Strategic ProgressMargin Expansion Trends - vinanet.vn
Press Release: Celularity Appoints Rick Gonzalez as Chief Commercial Officer - Moomoo
Number of shareholders of Celularity Inc. – NASDAQ:CELUW - TradingView
Price to sales forward of Celularity Inc. – NASDAQ:CELUW - TradingView
CELU Q4 2025 Earnings: Narrower-Than-Expected Loss Drives Stock HigherRevenue Growth Outlook - dars.gov.et
Celularity Inc. Warrant 2021-16.07.26 on Celularity -A- Financial Disclosures & SEC Filings - TradingView
Celularity Inc. Announces Resignation of Vincent LeVien as Director, Effective June 26, 2026 - marketscreener.com
Celularity Inc. Enters into a Loan Agreement with the Philip & Daniele Barach Family Trust - marketscreener.com
Celularity Company Profile & Introduction - Moomoo
Celularity Inc. Secures $1 Million Loan from Philip & Daniele Barach Family Trust – Form 8-K Filing Details and Key Agreement Terms 141519 - Minichart
CELULARITYSECURES $1 MLN LOAN FROM PHILIP & DANIELE BARACH FAMILY TRUSTSEC FILING - Moomoo
0.86%
0.31%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):